Constellation and Genentech Form Broad Epigenetics Collaboration with Buyout Option
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 2 (Table of Contents)
Published: 13 Feb-2012
DOI: 10.3833/pdr.v2012.i2.1682 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Constellation Pharmaceuticals has formed a major epigenetics collaboration with Roche’s Genentech unit that provides the biotech with committed funding of US$95 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS